It is good to see the FDA taking quick and firm action against companies improperly marketing their CBD products as effective against COVID-19, a devastating pandemic with no contemporary precedent.
There are several options provided by the US federal government that hemp and CBD businesses can take advantage of during these turbulent times.
If cannabis stores close, the state of Oregon would be depriving many patients who rely on retail cannabis stores access to their medicine. If retail cannabis stores remain open, does it make sense to limit access to medicinal patents?
Trademark registration is not simply a matter of racing to the USPTO to register a word or phrase that you wish to have exclusive rights to, even if you were the first to use the word or phrase.
I have observed that many people fail to “think properly” about how to handle financial downturns and find themselves thrashing in the dark, despite the fact that there are a number of simple and effective methods for managing cash flow that produce results.
As a service to our current clients and readers during these difficult times, we are offering a free 20-minute phone call to address your pressing issues – no strings attached.
For my talk, I compared and contrasted the hemp and CBD regulatory regimes in Europe and US. Although they parallel each other in some respects, particularly policy, they are fundamentally different in their approaches.
The FDA has yet to create a regulatory pathway for CBD. Does its most recent report to Congress herald a change?
Lawyers are bound by standards unique to any other profession. Absent a very select set of circumstances or exceptions, a lawyer may not reveal any information related to representing a client.
The 2020 Industrial Hemp Summit in Danville, VA was an enormous success. I enjoyed speaking on the “Regulatory Lab” panel.